Photodegradation of Ciprofloxacin and Levofloxacin by Au@ZnONPs-MoS2-rGO Nanocomposites

Abstract

This study aimed to investigate the photocatalytic performance of diverse zinc oxide catalysts containing gold nanoparticles (AuNPs), molybdenum disulfide (MoS2), and reduced graphene oxide (rGO) toward the degradation of the antibiotics levofloxacin (LFX) and ciprofloxacin (CFX) in aqueous solutions. The obtained results demonstrate that LFX is more resistant to degradation when compared with CFX and that the principal route of degradation under visible light is the formation of hydroxyl radicals. Photoluminescence (PL) measurements were employed to verify the inhibitory effect of electron–hole recombination when AuNPs, MoS2, and rGO are integrated into a semiconductor. The catalyst that achieved the highest percentage of CFX degradation was 1%Au@ZnONPs-3%MoS2-1%rGO, exhibiting a degradation efficiency of 96%, while the catalyst that exhibited the highest percentage of LFX degradation was 5%Au@ZnONPs-3%MoS2-1%rGO, displaying a degradation efficiency of 99.8%. A gas chromatography–mass spectrometry (GC-MS) analysis enabled the identification of reaction intermediates, facilitating the determination of a potential degradation pathway for both antibiotics. Additionally, recyclability assessments showed that the synthesized catalysts maintained stable photocatalytic efficiencies after 15 cycles, indicating that the heterostructures have the potential for further usage and may be tested with other organic contaminants as well.